{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "farnesylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q15831",
      "entity_text" : "LKB1",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "uaz:CVCL_9115" ],
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0564" ]
    }
  },
  "verbose_text" : "Strikingly, in all of the tissues / cells examined (liver, muscle and MEFs), ablation of LKB1 farnesylation significantly inhibited both basal and AMPK activity stimulated by treatments such as AICAR (XREF_FIG A and Supplementary Figure S4), muscle contraction (XREF_FIG A and XREF_FIG B) and phenformin that are dependent on LKB1 [XREF_BIBR - XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-08T16:58:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T16:45:31Z",
  "trigger" : "farnesylation",
  "evidence" : [ "LKB1 farnesylation" ],
  "pmc_id" : "3898322",
  "score" : 0
}